Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN101613263B details a novel MnO2 oxidation route for carvone. Achieve >99% purity with simplified workflow and reduced environmental impact for flavor industries.
Patent CN110698507A details a ligand-free Pd-catalyzed C-H alkenylation method for aryl vinyl silanes, offering significant cost reduction in pharmaceutical intermediate manufacturing.
Patent CN102690279A details a novel chiral zinc-nitrogen coordination compound. Discover cost-effective synthesis routes and supply chain advantages for pharmaceutical intermediates.
Patent CN112939994B details a novel low-loading lanthanum catalyzed method for synthesizing pyrano[2,3-b]indol-2-one scaffolds, offering significant cost reduction and scalability for pharmaceutical manufacturing.
Novel patent CN113045504B offers high-yield dacatinib route. Reduces complexity and enhances supply chain stability for pharmaceutical manufacturing.
Patent CN111518021A details a metal-free route to 3,5-disubstituted pyridines using styrenes and DMF, offering cost-effective pharma intermediate manufacturing.
Novel solid superacid catalysis method for Tinidazole reduces waste and enhances purity for reliable pharmaceutical intermediate supply chains.
Patent CN113956139B reveals mild CeBr3-H2O2 oxidation for carbonyl compounds ensuring cost reduction and supply chain reliability in pharmaceutical intermediates manufacturing.
Patent CN114591278A details a novel ethylene carbonate cyclization method for prucalopride intermediates, offering high purity, safety, and cost reduction in API manufacturing.
Patent CN103012406B reveals a scalable L-084 synthesis route. This method offers cost reduction in pharmaceutical intermediates manufacturing and enhanced supply chain reliability.
Patent CN104804004A reveals a copper-catalyzed asymmetric synthesis route offering high stereoselectivity and cost reduction in pharmaceutical intermediates manufacturing for global supply chains.
Patent CN103951549B offers high-yield celecoxib intermediate synthesis. Reduces waste and cost for pharmaceutical intermediates manufacturing supply chains.
Patent CN102199103B details an improved L-thyroxine sodium synthesis via oxidative coupling. Enhances yield and purity for reliable pharmaceutical intermediate supply chains.
Patent CN108046998A reveals high purity synthesis. Offers supply chain stability and cost efficiency for cosmetic active ingredient manufacturing.
Novel patent CN116836046B enables high-purity 4-Biphenylformaldehyde production. Achieve cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Enzymatic synthesis patent CN100396782C offers high purity stable isotope labeled amino acids with streamlined extraction and superior 15N utilization for research.
Patent CN112266364A reveals a metal-free hydrogenation method for tetrahydroquinoxalines using organic catalysts, offering significant cost reduction and supply chain stability for pharmaceutical manufacturers.
Novel Rh-catalyzed borylation method for high-purity pharmaceutical intermediates. Reduces cost and improves supply chain reliability for complex chiral building blocks.
Novel AlCl3 catalyzed route for prucalopride intermediate. High yield, safe scale-up, cost-effective manufacturing for global supply chains.
Patent CN103906728B reveals a novel catalytic method for tertiary aminoalcohol synthesis, offering significant supply chain and cost advantages for fine chemical intermediates manufacturing.